SAN DIEGO, Nov. 30, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (NASDAQ: PROG) today announced its intention to offer, subject to market and other conditions, $75 million aggregate principal amount of convertible senior notes due 2025 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Progenity also expects to grant the initial purchaser of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date notes are first issued, up to an additional $15 million principal amount of notes.
News
Progenity to Report Third Quarter 2020 Financial Results and Provide Corporate Update
SAN DIEGO, Nov. 03, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it will report third q… […]
News
Progenity to Present at 2020 San Antonio Breast Cancer Virtual Symposium
SAN DIEGO, Nov. 17, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, will be presenting at the San Antonio Breas… […]
News
Progenity Announces Proposed Public Offering of Common Stock
SAN DIEGO, Nov. 30, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (“Progenity”) (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it has c… […]
